Paul, Gregor, Strnad, Philipp, Wienand, Oliver, Krause, Ursula, Plecko, Thomas, Effenberger-Klein, Anja, Giel, Katrin Elisabeth, Junne, Florian, Galante-Gottschalk, Annette, Ehehalt, Stefan and Juergensen, Jan Steffen (2023). The humoral immune response more than one year after SARS-CoV-2 infection: low detection rate of anti-nucleocapsid antibodies via Euroimmun ELISA. Infection, 51 (1). S. 83 - 91. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1439-0973

Full text not available from this repository.

Abstract

Purpose Antibody assays against SARS-CoV-2 are used in sero-epidemiological studies to estimate the proportion of a population with past infection. IgG antibodies against the spike protein (S-IgG) allow no distinction between infection and vaccination. We evaluated the role of anti-nucleocapsid-IgG (N-IgG) to identify individuals with infection more than one year past infection. Methods S- and N-IgG were determined using the Euroimmun enzyme-linked immunosorbent assay (ELISA) in two groups: a randomly selected sample from the population of Stuttgart, Germany, and individuals with PCR-proven SARS-CoV-2 infection. Participants were five years or older. Demographics and comorbidities were registered from participants above 17 years. Results Between June 15, 2021 and July 14, 2021, 454 individuals from the random sample participated, as well as 217 individuals with past SARS-CoV-2 infection. Mean time from positive PCR test result to antibody testing was 458.7 days (standard deviation 14.6 days) in the past infection group. In unvaccinated individuals, the seroconversion rate for S-IgG was 25.5% in the random sample and 75% in the past infection group (P = < 0.001). In vaccinated individuals, the mean signal ratios for S-IgG were higher in individuals with prior infection (6.9 vs 11.2; P = < 0.001). N-IgG were only detectable in 17.1% of participants with past infection. Predictors for detectable N-IgG were older age, male sex, fever, wheezing and in-hospital treatment for COVID-19 and cardiovascular comorbidities. Conclusion N-IgG is not a reliable marker for SARS-CoV-2 infection after more than one year. In future, other diagnostic tests are needed to identify individuals with past natural infection.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Paul, GregorUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Strnad, PhilippUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wienand, OliverUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Krause, UrsulaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Plecko, ThomasUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Effenberger-Klein, AnjaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Giel, Katrin ElisabethUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Junne, FlorianUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Galante-Gottschalk, AnnetteUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Ehehalt, StefanUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Juergensen, Jan SteffenUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-684079
DOI: 10.1007/s15010-022-01830-x
Journal or Publication Title: Infection
Volume: 51
Number: 1
Page Range: S. 83 - 91
Date: 2023
Publisher: SPRINGER HEIDELBERG
Place of Publication: HEIDELBERG
ISSN: 1439-0973
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
Infectious DiseasesMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/68407

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item